IL99539A0 - Fibrinogen receptor antagonists and pharmaceutical compositions containing them - Google Patents

Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Info

Publication number
IL99539A0
IL99539A0 IL99539A IL9953991A IL99539A0 IL 99539 A0 IL99539 A0 IL 99539A0 IL 99539 A IL99539 A IL 99539A IL 9953991 A IL9953991 A IL 9953991A IL 99539 A0 IL99539 A0 IL 99539A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonists
fibrinogen receptor
fibrinogen
Prior art date
Application number
IL99539A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL99539A0 publication Critical patent/IL99539A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL99539A 1990-09-27 1991-09-20 Fibrinogen receptor antagonists and pharmaceutical compositions containing them IL99539A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58928290A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
IL99539A0 true IL99539A0 (en) 1992-08-18

Family

ID=24357362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99539A IL99539A0 (en) 1990-09-27 1991-09-20 Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP0479481A3 (cs)
JP (1) JPH0517498A (cs)
KR (1) KR920006373A (cs)
CN (1) CN1060293A (cs)
AU (1) AU8477891A (cs)
CA (1) CA2052057A1 (cs)
CS (1) CS294791A3 (cs)
FI (1) FI914532A7 (cs)
HU (1) HUT60751A (cs)
IE (1) IE913380A1 (cs)
IL (1) IL99539A0 (cs)
MX (1) MX9101311A (cs)
NO (1) NO913786L (cs)
PT (1) PT99095A (cs)
ZA (1) ZA917695B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693636A (en) * 1991-06-28 1997-12-02 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ATE188379T1 (de) * 1992-10-14 2000-01-15 Merck & Co Inc Fibrinogenrezeptor-antagonisten
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
US5786373A (en) * 1992-10-14 1998-07-28 Merck & Co., Inc. Fibrinogen receptor antagonists
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH08504194A (ja) * 1992-12-01 1996-05-07 メルク エンド カンパニー インコーポレーテッド フィブリノーゲンレセプターアンタゴニスト
EP0690847A1 (en) * 1993-03-29 1996-01-10 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
AU692438B2 (en) * 1993-03-29 1998-06-11 Astrazeneca Ab Heterocyclic derivatives as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5451578A (en) * 1994-08-12 1995-09-19 Merck & Co., Inc. Fibrinogen receptor antagonists
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
EP0479481A3 (en) 1993-07-28
PT99095A (pt) 1992-08-31
FI914532A7 (fi) 1992-03-28
IE913380A1 (en) 1992-04-08
NO913786L (no) 1992-03-30
FI914532A0 (fi) 1991-09-26
AU8477891A (en) 1992-04-02
CA2052057A1 (en) 1992-03-28
CS294791A3 (en) 1992-04-15
NO913786D0 (no) 1991-09-26
HU913074D0 (en) 1992-01-28
CN1060293A (zh) 1992-04-15
MX9101311A (es) 1992-05-04
HUT60751A (en) 1992-10-28
KR920006373A (ko) 1992-04-27
ZA917695B (en) 1992-05-27
JPH0517498A (ja) 1993-01-26
EP0479481A2 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
IL99539A0 (en) Fibrinogen receptor antagonists and pharmaceutical compositions containing them
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
IL99957A0 (en) Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
IL116323A0 (en) Tachykinin antagonists their preparation and pharmaceutical compositions containing them
IL96577A0 (en) Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them
IL93090A0 (en) Platinum compounds and pharmaceutical compositions containing the same
IL91126A0 (en) Substituted aminomethyl-tetralins and their heterocyclic analogues,their preparation and pharmaceutical compositions containing them
IL98176A0 (en) Bicyclic 1-aza-cycloalkanes,their preparation and pharmaceutical compositions containing them
GB9405317D0 (en) Fibrinogen receptor antagonists
IL118325A0 (en) Integrin receptor antagonists and pharmaceutical compositions containing them
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
GB9320799D0 (en) Fibrinogen receptor antagonists
IL90637A (en) Neurokinin a antagonists and pharmaceutical compositions containing them
IL99561A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
IL99009A0 (en) Polypeptides,their preparation and pharmaceutical compositions containing them
IL98911A0 (en) 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them
HUP0003548A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them